MEDICAL SCIENCES. For the article ''Initiating oncogenic event determines gene-expression patterns of human breast cancer models,''
, as well as a burst of apparently partial closings that were not well resolved. The closures were fast compared with the sampling interval of 2 ms. (B) Successive ramps repeated at 1/s showed fast gating to the residual state (first two ramps, dashed lines) and slow gating to the fully closed state (second two ramps, arrows). The channel was typically open at the onset of the ramp, closed at short latency, and then reopened (solid lines) at V j approaching near zero. T he reactions of nitric oxide (NO) with cell-free hemoglobin (Hb; unless otherwise noted, Hb denotes both oxygenated and deoxygenated Hb) and red blood cell (RBC)-encapsulated Hb have been investigated extensively for many years. The physiological importance of these reactions was established with the identification of NO as the endothelium-derived relaxation factor (1, 2) . However, the NO interaction with RBCencapsulated Hb is still a problem of considerable controversy. As NO is inactivated by oxyHb at an extremely high rate (k Ϸ10
) (3) (4) (5) , how is NO bioactivity preserved in the cardiovascular system? We have shown experimentally that an RBCfree zone near the vessel wall reduces the consumption of NO by RBCs (6) . In addition, NO does not react with RBCencapsulated Hb as rapidly as it does with cell-free Hb (7) because of an extracellular diffusion limitation (8) and a submembrane diffusion barrier consisting of the RBC cytoskeleton and other relatively NO-inert proteins such as MetHb (9, 10) .
Concurrent with the diffusion barrier model of NO preservation, another model has been proposed that involves new chemistry to explain the preservation of NO bioactivity in the vasculature (11) (12) (13) . One stipulation of this theory is that nitrosylhemoglobin [HbFe(II)NO] is produced from the cooperative binding of NO to the minor population of free heme on normoxic Hb (Ϸ99% oxyHb and 1% deoxyHb), thereby avoiding degradation of NO to nitrate. The formation of HbFe(II)NO in high concentrations is contrary to the original findings of Doyle and Hoekstra (3) and a later paper by Eich et al. (4) . More recently, the formation of HbFe(II)NO was investigated further by multiple laboratories (5, (14) (15) (16) (17) (18) .
Given that RBC-encapsulated Hb reacts much more slowly with NO than cell-free Hb, it is plausible that the reaction products differ under heterogeneous conditions in which locally high NO concentrations exist. As NO participates in a variety of reactions in biological solutions, the local NO concentration may determine the reaction pathway and thus product distribution. Here we examine the reaction of NO with cell-free Hb and RBC-encapsulated Hb by use of electron paramagnetic resonance (EPR) and mathematical simulation. We demonstrate that HbFe(II)NO is formed through the reduction of MetHb in locally high NO regions, and that RBCs facilitate the formation of HbFe(II)NO under this condition.
Materials and Methods
Chemicals. DEA͞NO, 2-(N,N-diethylamino)diazenolate 2-oxide, was purchased from Alexis (San Diego). HPLC water, potassium cyanide, iodine, sodium hydroxide, and acetic acid were purchased from Fisher Scientific. Sephadex G-25, ␣-cellulose, microcrystalline cellulose, EDTA, Hepes, potassium iodide, and potassium ferricyanide were purchased from Sigma.
Preparation of oxyHb and RBCs. Bovine blood was collected in a heparinized (10 units͞ml) container. The plasma and buffy coat were removed after centrifugation at 800 ϫ g for 10 min. The cells were resuspended and washed three times in a buffer containing 40 mM Hepes͞120 mM NaCl͞5 mM glucose at pH 7.4, 285 milliosmolar (mOsm). After each wash, the cells were centrifuged at 800 ϫ g for 10 min. RBCs were purified by filtration through a mixture of ␣-cellulose and microcrystalline cellulose. All solutions for preparing proteins were at 4°C. Cell lysate was prepared by lysing purified RBCs with 5 mM sodium phosphate solution, pH 8.0, or freeze lysis and centrifuging at 22,000 ϫ g, 4°C, for 30 min. When needed, oxyHb was isolated by passing the cell lysate through a Sephadex G-25 fine column.
NO Reaction with Free oxyHb and RBC. NO gas (Matheson) was purified by bubbling through deoxygenated 5 M NaOH as described elsewhere (19) and entrapped in a sealed-glass gascollection tube (Ace Glass). A saturated NO solution was prepared by bubbling the purified NO through a deoxygenated buffer consisting of 40 mM Hepes and 120 mM NaCl in a Hamilton air-tight syringe. Dilutions of the saturated NO solution were made as needed by adding deoxygenated buffer. DEA͞NO was prepared in 5 mM Tris solution at 9.4 pH adjusted to 300 mOsm with NaCl. The absorbance of DEA͞NO was measured at 250 nm, and the concentration was calculated with an extinction coefficient of 6.5 mM Ϫ1 ⅐cm Ϫ1 (20) . To both free oxyHb solutions and RBC suspensions, sufficient volumes of NO containing solution were added for a final concentration of 100 M NO (100 M NO solution or 65 M DEA͞NO). Samples were put in liquid nitrogen (for EPR) or on ice (for chemilu-minescence) within 1 min for NO solution additions or after 40 min for DEA͞NO additions. NO bolus additions to aerobically sealed samples were performed both inside and outside a controlled anaerobic chamber (Plas-Labs, Lansing, MI). RBC solutions at 30% hematocrit were determined to be the easiest to introduce consistently at the same volume into the EPR tube.
EPR Detection of MetHb and HbFe(II)NO.
After the addition of NO and immediate mixing, 200 l of each sample was introduced into 3-mm-i.d. clear fused-quartz tubes and plunged into liquid nitrogen. The EPR spectrum of each sample then was measured on a Bruker (Billerica, MA) EMX spectrometer in the X band at 77 K by using a suprasil liquid-nitrogen finger Dewar (Wilmad, Buena, NY) in a Bruker 4119HS-W1 high-sensitivity cavity. The high-sensitivity cavity has a measured signal-to-noise ratio approximately six times higher than a standard cavity. To measure both MetHb and HbFe(II)NO (oxyHb is EPR-silent) in the same scan, a sweep width of 3,995 G (1 G ϭ 0.1 mT) centered at 2,474 G was taken. The spectrometer was operated at 9.35 GHz, 10.1-mW microwave power, 15-G modulation amplitude, 100-kHz modulation frequency, and 20.48-ms time constant. Under these conditions, the power was not saturated. The sweep time was 41.94 s while two or four scans were taken of each sample. Detailed spectra of HbFe(II)NO were taken under the same conditions as described above except for the following. A modulation amplitude of 4 G was used with an 81.92-ms time constant and a sweep width of 400 G centered at 3,288 G. Four or eight scans were taken. Both MetHb and HbFe(II)NO were quantified by double integration using WINEPR SYSTEM 2.11 (Bruker), and comparison with a calibration curve generated by measuring UV-visible standardized MetHb and HbFe(II)NO samples in the EPR instrument.
Chemiluminescent Detection of S-Nitrosohemoglobin (SNO-Hb).
RBCs were lysed with two volumes of 0.5 mM EDTA͞10 mM sodium phosphate buffer, pH 7.2. Cytosol and membrane fractions were separated by centrifugation for 30 min at 16,000 ϫ g, 4°C. SNO-Hb was detected according to Gladwin et al. (14) . In short, the cytosol fraction was diluted (1:4) in a mixture of 0.2 M KCN͞0.2 M K 2 Fe(CN) 6 ͞0.5 mM EDTA͞2% Triton X-100 solution to oxidize any Fe(II)NO species. Samples were lightprotected and incubated at room temperature for 30 min before purification of the Hb fraction in a Sephadex G-25 column. Purified Hb then was injected into a mixture of 50 mg of potassium iodide and one iodine crystal in 9 ml of 80% acetic acid to release NO from SNO-Hb. The released NO was detected via the chemiluminescent reaction with ozone by using a Sievers NOA 280 (Ionics Instruments, Boulder, CO).
Mathematical Modeling. To simulate the reaction of a saturated NO bolus with cell-free Hb solutions, the bolus was assumed to be spherical in shape and surrounded by a similar sphere of Hb solution (Fig. 1a) . Taking advantage of the symmetry, one fourth of the resultant geometry was modeled. A no-flux symmetry condition was imposed at the outside boundary of the Hb solution for all reactants. To simulate the RBC reaction with NO, the RBC was assumed to be spherical and surrounded by NO solution (Fig. 1b) . For the RBC simulations, a permeability boundary condition was imposed at the RBC membrane (21) . The reactions considered and relevant parameters are listed in Table 1 . FEMLAB 2.0 (COMSOL, Los Angeles) on MATLAB 6 R12 (Mathworks, Natick, MA) was used to model the time-and space-dependent reactions of NO with RBCs and Hb. The geometry is available at http:͞͞www.seas.ucla.edu͞ϳliaoj͞ no.htm.
Results
Products of the NO Reaction with oxyHb Depend on Local Concentrations. In many in vitro experiments, a bolus of saturated (Ϸ2 mM) NO solution is added to a sub-mM solution of oxyHb for a final NO concentration in physiologically relevant regimes (nM-M). Yet, under physiological conditions the local concentration of NO generally does not exceed M concentrations, let alone achieve mM concentrations. Given this situation, studies using bolus NO may skew conclusions applied to the physiological roles of NO because of transient and locally high NO concentrations that may lead to different reactions. To detect whether the reaction of NO with oxyHb depends on the local concentration of NO, a series of experiments was performed by using a saturated NO bolus, or DEA͞NO, which was well mixed for the equal distribution of locally low concentrations of NO.
The addition of 100 M (final concentration) NO as a saturated bolus to a series of oxyHb solutions resulted in the formation of MetHb, HbFe(II)NO, and SNO-Hb as also shown by others (12) . Representative EPR spectra for the reaction of 100 M NO solution with 6, 10, and 20 mM oxyHb are shown The addition of a saturated bolus to an RBC suspension was modeled by zooming in on a region where a single RBC is surrounded by the NO bolus. The RBC was modeled as a sphere enclosed by a sphere of saturated NO solution. For both the free-oxyHb and RBC reaction with a saturated NO bolus, the reactions considered and parameters are listed in Table 1 . in Fig. 2a . In line with the classical model of NO reaction with oxyHb, MetHb was the primary product formed (Fig. 2b) . HbFe(II)NO was formed also but in much smaller quantities and was attenuated by increasing the concentration of oxyHb (Fig.  2c) . Addition of the NO bolus to an aerobically sealed sample in an aerobic or anaerobic environment had no effect on the HbFe(II)NO yield (data not shown). Increasing the concentration of oxyHb resulted in virtually no change in the formation of SNO-Hb (Fig. 2c) . In contrast, by using 65 M DEA͞NO (each molecule of DEA͞NO releases 1.5 molecules of NO) as the NO source, only MetHb was detected (Fig. 2) . DEA͞NO was determined not to destabilize HbFe(II)NO or SNO-Hb (data not shown). SNO-Hb was stable under our experimental conditions.
HbFe(II)NO Is Formed Through the Reduction of MetHb in Heteroge-
neous Solutions. Although direct nitrosylation (the binding of NO to free heme) has been proposed as the primary mode of HbFe(II)NO formation under normoxic conditions (12), we propose another viable pathway for HbFe(II)NO formation after addition of NO as a bolus (Fig. 3a) :
According to this mechanism, NO first reacts with oxyHb at the boundary of the NO bolus to form MetHb. After local oxyHb is depleted, NO reduces locally available MetHb to deoxyHb and produces NO ϩ , which is hydrolyzed to form N 2 . . deoxyHb can be nitrosylated to form HbFe(II)NO by binding with another NO molecule. In summary, three molecules of NO react with the same heme group successively to convert oxyHb to HbFe(II)NO. These reactions occur locally and transiently before the NO bolus is mixed completely. To test this hypothesis, we added 10 mM cyanide into both the NO bolus and Hb solution to trap MetHb as it forms (22) . Converting MetHb to cyano-MetHb prevents reduction to deoxyHb. As measured with EPR, 10 mM cyanide attenuated the formation of HbFe(II)NO below the detection limit (Ϸ0.5 M; Fig. 3 b and c) . The presence of 10 mM cyanide was determined not to destabilize HbFe(II)NO under these experimental conditions (data not shown). This result directly implicates MetHb as an intermediary in the formation of HbFe(II)NO when a saturated NO bolus is used. However, even with 10 mM cyanide, the formation of SNO-Hb was evident when an NO bolus was added to an aerobic sample in an anaerobic environment (Fig.  3c) , suggesting that SNO-Hb was not formed through the generation of NO ϩ from the reduction of MetHb. When NO solution was added in an aerobic environment, a sequential rise in SNO-Hb formation was evident (data not shown). Thus, it is possible that SNO-Hb is formed through N 2 O 3 present in the NO stock solution. N 2 O 3 formation after the addition of NO was not possible kinetically according to our mathematical simulation described below.
To support the mechanism further, we used a mathematical model to simulate the experimental condition. The model considers the NO bolus as a sphere dropped into an oxyHb solution (Fig. 1a) . NO and all Hb species were allowed to diffuse out and into the bolus, respectively. The reactions (1-3) shown above are allowed to occur at any region according to the kinetic constants. The reaction of NO with dioxygen (k ϭ 2.0 ϫ 10 6 M Ϫ2 ⅐s
Ϫ1
) was slow, because this reaction is second order in NO and the local concentration of dioxygen was low, and whether it was included in the simulation did not alter the result.
Simulating the reaction of a 2 mM NO bolus in a 6 mM free-oxyHb solution (both local concentrations) results in primarily MetHb and minor amounts of HbFe(II)NO formation (Table 2) , which is consistent with our experimental observation. Further, HbFe(II)NO is formed only near the bolus where the concentration of MetHb is maximal and oxyHb and deoxyHb have been depleted (Fig. 4a) . As the concentration of oxyHb solution increased, the local NO concentration at the bolus boundary decreased, as did HbFe(II)NO formation (Fig. 4b) .
HbFe(II)NO Formation Enhanced but SNO-Hb Formation Diminished in
RBC Suspensions. Because the products of the NO reaction with cell-free Hb depend on the heterogeneity of the solution, it is possible that the reaction of a saturated NO bolus with an RBC suspension results in different products compared with the reaction with a cell-free Hb solution. To test this hypothesis, we added NO bolus from stock solutions of 2 or 0.5 mM to a 30% RBC suspension (equivalent to 6 mM heme in solution) for a final concentration of 100 M NO. As a control, we added the same NO bolus to 6 mM cell-free Hb solution. The reaction of 100 M NO with a 30% RBC suspension results in a greater formation of HbFe(II)NO (Fig. 5a ) compared with a heme equivalent solution of cell-free oxyHb using a saturated NO solution as the NO source. Reducing the concentration of the NO solution from 2 to 0.5 mM NO had little effect on this Table 2 . Results from the simulation of a 2 mM NO bolus with free or encapsulated Hb (Fig. 1 a and  b, SNO-Hb was a minor product in the reaction of NO with Hb solutions. In the reactions of cell-free Hb with NO released from DEA͞NO solution and the reaction of a bolus of NO solution with RBCs, SNO-Hb was undetectable. SNO-Hb formation in the bolus NO reaction with cell-free Hb was not blocked by cyanide, suggesting that it was formed from a MetHbindependent pathway. In addition, the concentration of SNO-Hb increased with each bolus addition when added in an aerobic environment, suggesting that contamination occurred, possibly through the syringe needle. Hence the most likely explanation for SNO-Hb formation is that N 2 O 3 contaminated the NO stock solution. However, low concentrations of S-nitrosated species have been detected in vivo, suggesting that other pathways exist for S-nitrosation (14, 23) .
In our hands, the reaction of NO with RBC resulted in greater formation of HbFe(II)NO compared with the reaction with cell-free Hb. Using cyanide-addition experiments, we conclude that MetHb reduction is involved in the enhanced formation of HbFe(II)NO in the RBC. To help explain why HbFe(II)NO formation is enhanced in RBC-encapsulated Hb, we used mathematical modeling to suggest possible scenarios in which the reaction of NO with Hb could result in greater HbFe(II)NO formation. From these results, we conclude that several factors in combination may be involved. (i) Because the mobility of the RBC is much lower than cell-free Hb, the RBC can be considered to be essentially stationary. Lowering the diffusivity of Hb resulted in enhanced HbFe(II)NO formation. (ii) Because the RBC possesses a diffusion barrier, whether it be external diffusion or a submembrane barrier, the consumption of NO is slowed, which allows the local concentration of NO to be sustained at higher concentrations, allowing the enhanced formation of MetHb and its eventual reduction and nitrosylation. (iii) MetHb attachment to the cytoskeleton has been observed (24) . If MetHb were to block NO entry points in the cytoskeleton, then a molecule of NO would encounter MetHb before diffusing further into the RBC. Mathematical simulations suggest that the last scenario is most effective in explaining the data. In other simulations, increasing the adduct reaction rate, as suggested by Gow et al. (12) , or increasing the deoxyHb content to 2% in the RBC also promotes HbFe(II)NO formation, but these mechanisms cannot be blocked by cyanide, contrary to our experimental data. Therefore, the existence of cytoskeletonassociated MetHb seems to be the most feasible explanation, although other possibilities may exist.
Recently, Huang et al. (15) showed that the reaction of a saturated NO bolus with oxyHb under normoxic conditions results in similar or greater concentrations of HbFe(II)NO compared with the reaction with RBC-encapsulated Hb. However, as the reaction products are formed in heterogeneous conditions, perturbations of these conditions such as the method of mixing, the concentration of Hb, or the manner by which NO solution is added could produce results different from those presented here.
The importance of understanding the metabolic fate and regulation of NO in the vasculature is of the utmost importance to develop therapeutic strategies based on NO biology. Here we demonstrated that under physiological conditions of low local NO, oxyHb is oxidized by NO to form MetHb. However, if the local concentration of NO were to increase to sufficiently high levels because of the induction of inducible NO synthase or from inhalation of NO under normoxic conditions, HbFe(II)NO formation may occur from the reduction of MetHb. Recently, the formation of HbFe(II)NO in concentrations observed here has been detected in blood by using NO inhalation therapy (14, 25) . It is possible that some formation of HbFe(II)NO is through the reduction of MetHb, which exists in locally high concentrations either in paths of NO entry into the RBC or by newly formed through the oxidation of oxyHb near the membrane surface. These mechanisms also may be responsible for HbFe(II)NO formed because of high nitrosative stress.
Note Added in Proof. Zhang and Hogg (28) have demonstrated artifacts from the addition of an NO bolus to myoglobulin solutions, which is relevant to the data presented here.
